U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Na.O3V
Molecular Weight 121.9295
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM METAVANADATE

SMILES

[Na+].[O-][V](=O)=O

InChI

InChIKey=CMZUMMUJMWNLFH-UHFFFAOYSA-N
InChI=1S/Na.3O.V/q+1;;;-1;

HIDE SMILES / InChI

Molecular Formula O3V
Molecular Weight 98.9397
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

There is no information about pharmacological and biological application of vanadium pentoxide (V2O5). However, inhalation of this substance is a toxic for mammalian and repeated exposures to V2O5 containing particles may augment lung carcinogenesis in susceptible individuals through oxidative stress mediated pathways.

CNS Activity

Curator's Comment: Known to be CNS penetrant in mouse. Human data not available blood-brain barrier disruption

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals.
2009-12
Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.
2009-10-15
STAT-1 signaling in human lung fibroblasts is induced by vanadium pentoxide through an IFN-beta autocrine loop.
2008-03-15
Genomic analysis of human lung fibroblasts exposed to vanadium pentoxide to identify candidate genes for occupational bronchitis.
2007-04-25
Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ.
2006-11-29
Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases.
2003-05
Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years.
2002-10
Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts.
2001-02
Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms.
1998-08
Patents

Sample Use Guides

toxicity study: Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation.
Route of Administration: Respiratory
It was study to evaluate the effect of vanadium pentoxide (V2O5) on endothelial cells since they are key participants in the pathogenesis of several cardiovascular and inflammatory diseases. Cell adhesion, the expression of adhesion molecules and oxidative stress, as well as proliferation, morphology and cell death of human umbilical vein endothelial cells (HUVECs) exposed to V2O5, were evaluated. Vanadium pentoxide at a 3.12 µg cm(-2) concentration induced an enhanced adhesion of the U937 macrophage cell line to HUVECs, owing to an increased expression of late adhesion molecules. HUVECs exposed to V2O5 showed an increase in ROS and nitric oxide production, and a diminished proliferation. These changes in vanadium-treated HUVECs were accompanied by severe morphological changes and apoptotic cell death. Vanadium pentoxide induced serious endothelial cell damage, probably related to the increased cardiovascular morbidity and mortality observed in individuals living in highly air-polluted areas.
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:20:38 GMT 2025
Edited
by admin
on Mon Mar 31 20:20:38 GMT 2025
Record UNII
252S9L5606
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-79535
Preferred Name English
SODIUM METAVANADATE
MI   WHO-DD  
Common Name English
Sodium Metavanadate [WHO-DD]
Common Name English
VANADATE (VO31-), SODIUM (1:1)
Common Name English
SODIUM METAVANADATE [MI]
Common Name English
SODIUM VANADIUM TRIOXIDE
Common Name English
SODIUM VANADATE
Common Name English
SODIUM VANADATE(V)
Common Name English
SODIUM TRIOXOVANADATE
Common Name English
Classification Tree Code System Code
DSLD 3866 (Number of products:1)
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
Code System Code Type Description
EVMPD
SUB22097
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
WIKIPEDIA
SODIUM METAVANADATE
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
MERCK INDEX
m10044
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY Merck Index
NSC
79535
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
DRUG BANK
DB14702
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
CAS
13718-26-8
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
CHEBI
75221
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
CHEBI
35607
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
SMS_ID
100000085612
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
PUBCHEM
4148882
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
ECHA (EC/EINECS)
237-272-7
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
EPA CompTox
DTXSID3044336
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
FDA UNII
252S9L5606
Created by admin on Mon Mar 31 20:20:38 GMT 2025 , Edited by admin on Mon Mar 31 20:20:38 GMT 2025
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS